A review article of inflammatory bowel disease treatment and pharmacogenomics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
A review article of inflammatory bowel disease treatment and pharmacogenomics ; volume:12 ; number:1 ; day:30 ; month:3 ; year:2023 ; pages:1-19 ; date:12.2023
Beni-Suef University Journal of Basic and Applied Sciences / Ǧāmiʿat Banī-Suwaif ; 12, Heft 1 (30.3.2023), 1-19, 12.2023
- Urheber
-
Eltantawy, Nashwa
El-Zayyadi, Islam Abd El-Hamid
Elberry, Ahmed A.
Salah, Layla M.
Abdelrahim, Mohamed E. A.
Kassem, Amira B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43088-023-00361-0
- URN
-
urn:nbn:de:101:1-2023081521005655736317
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Eltantawy, Nashwa
- El-Zayyadi, Islam Abd El-Hamid
- Elberry, Ahmed A.
- Salah, Layla M.
- Abdelrahim, Mohamed E. A.
- Kassem, Amira B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Morning light treatment for inflammatory bowel disease: a clinical trial
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
Morning light treatment for inflammatory bowel disease: a clinical trial
Pharmacogenomics
New treatment options for inflammatory bowel diseases
Inflammatory bowel disease
6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
Biologic treatment of Japanese patients with inflammatory bowel disease
The pharmacogenomics journal
Pharmacogenomics and toxicogenomics
Pharmacogenomics and toxicogenomics
Smart bionanomaterials for treatment and diagnosis of inflammatory bowel disease
Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?